These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 31595422)
21. Control of β-Site Amyloid Precursor Protein-Cleaving Enzyme-1 Expression by Protein Kinase C-λ/ι and Nuclear Factor κ-B. Sajan MP; Leitges M; Park C; Diamond DM; Wu J; Hansen BC; Duncan MA; Apostolatos CA; Apostolatos AH; Kindy M; Farese RV Curr Alzheimer Res; 2021; 18(12):941-955. PubMed ID: 34951366 [TBL] [Abstract][Full Text] [Related]
22. BACE1 in Alzheimer's disease. Sathya M; Premkumar P; Karthick C; Moorthi P; Jayachandran KS; Anusuyadevi M Clin Chim Acta; 2012 Dec; 414():171-8. PubMed ID: 22926063 [TBL] [Abstract][Full Text] [Related]
23. Transcriptional and translational regulation of BACE1 expression--implications for Alzheimer's disease. Rossner S; Sastre M; Bourne K; Lichtenthaler SF Prog Neurobiol; 2006 Jun; 79(2):95-111. PubMed ID: 16904810 [TBL] [Abstract][Full Text] [Related]
24. Dimethyl fumarate exerts neuroprotection by modulating calcineurin/NFAT1 and NFκB dependent BACE1 activity in Aβ Rajput MS; Nirmal NP; Rathore D; Dahima R Brain Res Bull; 2020 Dec; 165():97-107. PubMed ID: 32877715 [TBL] [Abstract][Full Text] [Related]
25. Disrupted intracellular calcium regulates BACE1 gene expression via nuclear factor of activated T cells 1 (NFAT 1) signaling. Cho HJ; Jin SM; Youn HD; Huh K; Mook-Jung I Aging Cell; 2008 Mar; 7(2):137-47. PubMed ID: 18081741 [TBL] [Abstract][Full Text] [Related]
26. BACE1 structure and function in health and Alzheimer's disease. Cole SL; Vassar R Curr Alzheimer Res; 2008 Apr; 5(2):100-20. PubMed ID: 18393796 [TBL] [Abstract][Full Text] [Related]
27. Mitochondrial TXN2 attenuates amyloidogenesis via selective inhibition of BACE1 expression. Li KY; Xiang XJ; Song L; Chen J; Luo B; Wen QX; Zhong BR; Zhou GF; Deng XJ; Ma YL; Hu LT; Chen GJ J Neurochem; 2021 May; 157(4):1351-1365. PubMed ID: 32920833 [TBL] [Abstract][Full Text] [Related]
28. miR-16-5p and miR-19b-3p prevent amyloid β-induced injury by targeting BACE1 in SH-SY5Y cells. Zhang N; Li WW; Lv CM; Gao YW; Liu XL; Zhao L Neuroreport; 2020 Feb; 31(3):205-212. PubMed ID: 31876684 [TBL] [Abstract][Full Text] [Related]
29. Amyloid-β protein (Aβ) Glu11 is the major β-secretase site of β-site amyloid-β precursor protein-cleaving enzyme 1(BACE1), and shifting the cleavage site to Aβ Asp1 contributes to Alzheimer pathogenesis. Deng Y; Wang Z; Wang R; Zhang X; Zhang S; Wu Y; Staufenbiel M; Cai F; Song W Eur J Neurosci; 2013 Jun; 37(12):1962-9. PubMed ID: 23773065 [TBL] [Abstract][Full Text] [Related]
30. Swedish mutant APP-based BACE1 binding site peptide reduces APP β-cleavage and cerebral Aβ levels in Alzheimer's mice. Li S; Hou H; Mori T; Sawmiller D; Smith A; Tian J; Wang Y; Giunta B; Sanberg PR; Zhang S; Tan J Sci Rep; 2015 Jun; 5():11322. PubMed ID: 26091071 [TBL] [Abstract][Full Text] [Related]
31. Palmitate Increases β-site AβPP-Cleavage Enzyme 1 Activity and Amyloid-β Genesis by Evoking Endoplasmic Reticulum Stress and Subsequent C/EBP Homologous Protein Activation. Marwarha G; Rostad S; Lilek J; Kleinjan M; Schommer J; Ghribi O J Alzheimers Dis; 2017; 57(3):907-925. PubMed ID: 28304295 [TBL] [Abstract][Full Text] [Related]
32. Presynaptic dystrophic neurites surrounding amyloid plaques are sites of microtubule disruption, BACE1 elevation, and increased Aβ generation in Alzheimer's disease. Sadleir KR; Kandalepas PC; Buggia-Prévot V; Nicholson DA; Thinakaran G; Vassar R Acta Neuropathol; 2016 Aug; 132(2):235-256. PubMed ID: 26993139 [TBL] [Abstract][Full Text] [Related]
33. Salvianolic Acid B Inhibits Aβ Generation by Modulating BACE1 Activity in SH-SY5Y-APPsw Cells. Tang Y; Huang D; Zhang MH; Zhang WS; Tang YX; Shi ZX; Deng L; Zhou DH; Lu XY Nutrients; 2016 Jun; 8(6):. PubMed ID: 27258307 [TBL] [Abstract][Full Text] [Related]
34. The beta-secretase, BACE: a prime drug target for Alzheimer's disease. Vassar R J Mol Neurosci; 2001 Oct; 17(2):157-70. PubMed ID: 11816789 [TBL] [Abstract][Full Text] [Related]
35. Oxidative stress increases BACE1 protein levels through activation of the PKR-eIF2α pathway. Mouton-Liger F; Paquet C; Dumurgier J; Bouras C; Pradier L; Gray F; Hugon J Biochim Biophys Acta; 2012 Jun; 1822(6):885-96. PubMed ID: 22306812 [TBL] [Abstract][Full Text] [Related]
36. Trientine reduces BACE1 activity and mitigates amyloidosis via the AGE/RAGE/NF-κB pathway in a transgenic mouse model of Alzheimer's disease. Wang CY; Xie JW; Xu Y; Wang T; Cai JH; Wang X; Zhao BL; An L; Wang ZY Antioxid Redox Signal; 2013 Dec; 19(17):2024-39. PubMed ID: 23541064 [TBL] [Abstract][Full Text] [Related]
37. 3K3A-activated protein C blocks amyloidogenic BACE1 pathway and improves functional outcome in mice. Lazic D; Sagare AP; Nikolakopoulou AM; Griffin JH; Vassar R; Zlokovic BV J Exp Med; 2019 Feb; 216(2):279-293. PubMed ID: 30647119 [TBL] [Abstract][Full Text] [Related]
38. BACE1: the beta-secretase enzyme in Alzheimer's disease. Vassar R J Mol Neurosci; 2004; 23(1-2):105-14. PubMed ID: 15126696 [TBL] [Abstract][Full Text] [Related]
39. Berberine Alleviates Amyloid-Beta Pathology in the Brain of APP/PS1 Transgenic Mice via Inhibiting β/γ-Secretases Activity and Enhancing α-Secretases. Cai Z; Wang C; He W; Chen Y Curr Alzheimer Res; 2018; 15(11):1045-1052. PubMed ID: 29962345 [TBL] [Abstract][Full Text] [Related]
40. Melatonin regulates the transcription of βAPP-cleaving secretases mediated through melatonin receptors in human neuroblastoma SH-SY5Y cells. Panmanee J; Nopparat C; Chavanich N; Shukla M; Mukda S; Song W; Vincent B; Govitrapong P J Pineal Res; 2015 Oct; 59(3):308-20. PubMed ID: 26123100 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]